Recent onset
Showing 1 - 25 of >10,000
Type 1 Diabetes, Diabetes, Type 1 Trial in Miami (CELZ-201 Administration, Control Group)
Not yet recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- CELZ-201 Administration
- Control Group
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Nov 15, 2022
Paroxysmal Atrial Fibrillation (PAF) Trial in Belgium, Netherlands (Flecainide Acetate)
Completed
- Paroxysmal Atrial Fibrillation (PAF)
- Flecainide Acetate
-
Bonheiden, Belgium
- +8 more
Dec 2, 2022
Schizophrenia Trial in Milan (Lurasidone)
Recruiting
- Schizophrenia
-
Milan, Lombardy, ItalyU.O.C. Psichiatria - Fondazione IRCCS Ca' Granda Ospedale Maggio
Apr 22, 2022
Rheumatoid Arthritis, Inflammatory Arthritis Trial in Sherbrooke
Recruiting
- Rheumatoid Arthritis
- Inflammatory Arthritis
-
Sherbrooke, Quebec, CanadaCentre hospitalier universitaire de Sherbrooke
May 23, 2022
Psychotic Disorder Trial in Basel (D-serine, Placebo)
Recruiting
- Psychotic Disorder
- D-serine
- Placebo
-
Basel, Basel-Stadt, SwitzerlandUPK Basel
Jan 21, 2022
Schizophrenia, Psychotic Disorder Trial in France (left fronto-temporal transcranial Direct Current Stimulation (tDCS))
Not yet recruiting
- Schizophrenia
- Psychotic Disorder
- left fronto-temporal transcranial Direct Current Stimulation (tDCS)
-
La Tronche, Auvergne-Rhône-Alpes, France
- +3 more
Jun 27, 2022
Early Systemic Stabilization Therapy on Recent Onset Vitiligo
Completed
- Vitiligo
- (no location specified)
Sep 3, 2021
COVID-19 Trial in Torino (Standard Therapy Protocol (STP), STP + Standard Plasma (SP), STP + COVID-19 Convalescent Plasma (CP))
Completed
- COVID-19
- Standard Therapy Protocol (STP)
- +2 more
-
Torino, ItalyAO Città della salute e della scienza di Torino
Feb 21, 2022
Early Psychosis, Psychotic Disorders Trial in Hong Kong (Peer-led self-management program, Psycho-education group, Usual care)
Recruiting
- Early Psychosis
- Psychotic Disorders
- Peer-led self-management program
- +2 more
-
Hong Kong, Hong KongIntegrated Community Centers for Mental Wellness
Oct 20, 2021
Recent-onset Psychosis Trial in Chengdu, Hong Kong (Mindfulness-based cognitive therapy (psychosis), Psychoeducation
Completed
- Recent-onset Psychosis
- Mindfulness-based cognitive therapy (psychosis)
- Psychoeducation (psychosis)
-
Chengdu, China
- +1 more
Sep 20, 2021
Serial Evaluation of Recent-onset Dilated Cardiomyopathy
Recruiting
- Dilated Cardiomyopathy
- 12 months of guideline-directed heart failure therapy
-
London, United KingdomImperial College
Jun 30, 2021
Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )
Completed
- Diabetes Mellitus, Type 2
- Dorzagliatin
- placebo
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Jul 19, 2022
Dual Diagnosis Trial in Glostrup (Cannabidiol, Risperidone)
Recruiting
- Dual Diagnosis
-
Glostrup, DenmarkCenter for Neuropsychiatric Schizophrenia Research
Jun 7, 2021
Schizophrenia (Recent-onset) Trial in Los Angeles (paliperidone palmitate, risperidone)
Completed
- Schizophrenia (Recent-onset)
- paliperidone palmitate
- risperidone
-
Los Angeles, CaliforniaUCLA Semel Institute for Neuroscience and Human Behavior
Apr 7, 2022
Atrial Fibrillation Trial in Netherlands (Rate control, Pharmacological or electrical cardioversion)
Recruiting
- Atrial Fibrillation
- Rate control
- Pharmacological or electrical cardioversion
-
Maastricht, Limburg, Netherlands
- +13 more
Dec 2, 2021
Cardiomyopathy, Heart Failure Trial in Houston (Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell
Completed
- Cardiomyopathy
- Heart Failure
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 11, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- IMCY-0141
- +2 more
-
Chisinau, Moldova, Republic ofRepublican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022
Development of Predictive Biomarkers
Completed
- Type1diabetes
- Mixed Meal Tolerance Test
-
Milwaukee, WisconsinMedical College of Wisconsin
Nov 28, 2021
Type 1 Diabetes Trial in United States (mAb hOKT3gamma1(Ala-Ala), Teplizumab, Placebo Arm)
Completed
- Type 1 Diabetes Mellitus
- mAb hOKT3gamma1(Ala-Ala), Teplizumab
- Placebo Arm
-
San Francisco, California
- +3 more
Aug 11, 2021
Schizophrenia Spectrum Disorders, Cannabis Use Trial in Los Angeles, Baltimore, Catonsville (Cannabidiol (CBD), Placebo)
Withdrawn
- Schizophrenia Spectrum Disorders
- Cannabis Use
- Cannabidiol (CBD)
- Placebo
-
Los Angeles, California
- +2 more
Apr 14, 2021
Type 1 Diabetes Trial in Atlanta (Teplizumab)
Terminated
- Type 1 Diabetes Mellitus
-
Atlanta, GeorgiaAtlanta Diabetes Associates
Feb 4, 2022
Schizophrenia Trial in Korea, Republic of (abilify maintena)
Completed
- Schizophrenia
- abilify maintena
-
Busan, Korea, Republic of
- +4 more
Jan 25, 2021
Schizophrenia, Psychotic Disorders Trial in Belgium, Netherlands (olanzapine, ziprasidone)
Completed
- Schizophrenia
- Psychotic Disorders
-
Antwerpen, Belgium
- +6 more
Feb 18, 2021